Alert FDA Drug Safety-Recall
From the U.S. Food & Drug Administration Irbesartan Tablets Sciegen Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Irbesartan Tablets, USP 75…
From the U.S. Food & Drug Administration Irbesartan Tablets Sciegen Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Irbesartan Tablets, USP 75…
De Faakto Intelligence Research Observatory K9 Opioid Exposure/Overdose Methodology OSINT-research Situation K9 Opioid Exposure/Overdose Background Working dogs are…
Food & Drug Administration Drug Shortage Report Trifluoperazine Hydrochloride Tablets Status: Currently in Shortage Date first posted: 10/02/2018 Therapeutic Categories: Psychiatry 1 mg (NDC…
UPDATE: Potential Eye Damage from Alcon CyPass Micro-Stent Used to Treat Open-Angle Glaucoma: FDA Safety Communication 24 October 2018 Audience People who…
Food & Drug Administration SAFETY COMMUNICATION Increased Risk of Corneal Haze Associated with the Raindrop Near Vision Inlay: FDA Safety…
Food & Drug Administration Alert-MEDWATCH 23 October 2018 MedWatch – The FDA Safety Information and Adverse Event Reporting Program A new MedWatch…
U.S. Food & Drug Administration is reporting, Drug Shortages for, Ondansetron Hydrochloride Injection Diltiazem Hydrochloride ER (Twice-a-Day) Capsules For more information from the…
UPDATE 17 December 2018 From South China Morning Post, The deadly African swine fever virus is continuing to spread through…
De Faakto Intelligence Research Observatory FAAKT BOARD Chikungunya-Mosquito-Borne Viral Disease OSINT-research Situation Chikungunya-Mosquito-Borne Viral Disease Background Chikungunya is a mosquito-borne viral disease first described during an…
World Health Organization is Reporting Chikungunya – Sudan Disease outbreak news 15 October 2018 On 31 May 2018, the State Ministry of Health…